INTRODUCTION {#sec1-1}
============

Dizziness and vertigo are among the most common disorders in medicine, affecting approximately 20-30% of people in the general population.\[[@ref1][@ref2][@ref3]\] Dizziness is a general term used to express subjective complaints of the patients related to changes in sensation, movement, perception, or consciousness.\[[@ref3][@ref4]\] Vertigo is a subtype of dizziness, defined as an illusion of movement caused by asymmetric involvement of the vestibular system.\[[@ref1][@ref2][@ref4][@ref5][@ref6]\] The incidence of vertigo increases with age and is about two to three times higher in women than in men.\[[@ref2][@ref6]\] Dizziness or vertigo originates from a mismatch between three sensory systems: The vestibular, the visual, and the somatosensory systems. Therefore, vertigo/dizziness is a multisensory syndrome and not a single disease entity.\[[@ref3][@ref4][@ref5][@ref6][@ref7]\]

Different classifications of vertigo exist \[[Table 1](#T1){ref-type="table"}\] First of all, vertigo can be classified into true vertigo and pseudovertigo.\[[@ref8][@ref9][@ref10]\] True vertigo denotes a sense of rotation in one direction, which may be "subjective," when the subject feels that he is moving while the surrounding environment remains static or "objective" when he feels the surrounding objects are moving around him. The objective vertigo can itself be divided into rotary vertigo, in which the patient perceives that the space moves around him more or less vortically, into wavelike vertigo, in which the patient perceives that the space moves in a direction of oscillation on the transversal or longitudinal axis, and sussultatory vertigo, in which the patient perceives a feeling of dragging upward or downward (as in the elevator, or as floor which sinks). Pseudovertigo, more common than true vertigo, includes all sensations of imbalance, different from true vertigo. While true vertigo occurs as a result of primary neurological causes, non-neurological causes can often induce pseudovertigo. Furthermore, while true vertigo occurs as a single episode or as recurrent stereotyped attacks of defined durations, pseudovertigo, instead, occurs either as a very prolonged sensation lasting for hours or even days, or as momentary attacks.\[[@ref11]\] Furthermore, vertigo may occur as a normal response to certain stimuli; this form of vertigo is called physiological vertigo. Healthy people may experience vertigo when they are travelling by car, boat, or spaceship (motion sickness) or on looking down from a mountain or from a tall building (height vertigo).\[[@ref8][@ref9][@ref10][@ref11]\] Vertigo may also be caused by diseases affecting the labyrinth (peripheral vestibular vertigo), the central vestibular system (central vestibular vertigo) or other functional systems (non-vestibular vertigo); this form of vertigo is generally called "*pathological vertigo*."\[[@ref8][@ref9][@ref10][@ref11]\]

###### 

Characteristics of peripheral and central vertigo
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From a pathophysiological point of view, the vertigo can be classified into central, peripheral, and psychogenic; central vertigo is frequently accompanied by neurologic signs and symptoms, which are the result of a disease originating from the central nervous system (CNS).\[[@ref10][@ref11][@ref12]\] The most important causes of central vertigo are cerebellar hemorrhage, brainstem ischemia, and vertebrobasilar insufficiency; other causes include infections, trauma, CNS tumors, and multiple sclerosis.\[[@ref1][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17]\] The most common form of vertigo in patients is the peripheral vertigo, often accompanied by nausea or vomiting, with no other neurologic signs.\[[@ref12]\] The most common cause of peripheral vertigo is Benign Paroxysmal Positional vertigo (BPPV),\[[@ref18]\] a clinical syndrome with unknown exact etiology, characterized by recurrent, brief episodes of severe vertigo and rotary nystagmus, precipitated by specific positions of the head relative to gravity. The physical symptoms of BPPV may interfere with normal daily functional activities, but it can be easily and effectively treated if identified.\[[@ref18]\] It is known that BPPV incidence increases with age,\[[@ref19][@ref20][@ref21]\] whereas the prevalence of BPPV in the young adult population is very low;\[[@ref22]\] in older people, BPPV is often associated with depression, reduced activities of daily living, and falls.\[[@ref23]\] Other causes of peripheral vertigo are acute labyrinthitis,\[[@ref12]\] vestibular neuronitis,\[[@ref12][@ref24][@ref25]\] Meniere\'s disease,\[[@ref12][@ref24][@ref26]\] labyrinthic concussion,\[[@ref12][@ref24]\] cholesteatoma,\[[@ref12][@ref24]\] labyrinthine infarction /ischemia,\[[@ref12][@ref24][@ref27]\] labyrinthine fistula,\[[@ref12][@ref24]\] malignant otitis externa,\[[@ref12][@ref24]\] cerumen impaction,\[[@ref12][@ref24]\] and tympanic membrane rupture.\[[@ref12][@ref24]\] The most important characteristics of peripheral and central vertigo are reported in [Table 1](#T1){ref-type="table"}.

Psychogenic vertigo is a form of vertigo, which may occur concurrently with hyperventilation, anxiety, panic attacks, claustrophobia, agoraphobia, and other psychiatric disturbances including schizophrenia.\[[@ref28]\]

Several drugs and environmental chemicals, such as lead and mercury, can cause ototoxicity. The latter often causes damage to the inner ear or auditory nerve and leads to the occurrence of vertigo. The damage can be temporary or permanent.\[[@ref29][@ref30]\]

Since patients with vertigo often have difficulty to describe their symptoms, determination of causes can be very difficult. The diagnosis of vertigo is most often based upon history and clinical presentation of the patient. Very interesting clues for the diagnosis of vertigo, indeed, come from the patient\'s medical history, including drugs, trauma, or exposure to toxic substances. Age is associated with some underlying conditions that can cause vertigo. As an example, elderly patients, especially those with diabetes or hypertension, are at higher risk of cerebrovascular causes of vertigo. For the diagnosis of vertigo, the physician must first ask a series of questions regarding family history, including hereditary conditions such as migraine and risk factors for cerebrovascular diseases. After confirming that the patient has vertigo, the physician must determine whether the subject presents a peripheral or central origin.\[[@ref5][@ref15][@ref17][@ref31]\] Associated symptoms such as pain, nausea, vomiting, hearing loss, or neurologic symptoms can help differentiate the cause of vertigo: Indeed, in severe episodes of Ménière\'s disease, in acute vestibular neuronitis and in BPPV, vertigo often is associated with nausea or vomiting, whereas if the cause of vertigo is central, nausea and vomiting tend to be less severe.\[[@ref17][@ref23][@ref24][@ref25][@ref31]\] Furthermore, most causes of vertigo with hearing loss are peripheral, whereas neurologic symptoms such as ataxia, weakness, changes in vision or hearing, paraesthesia, dysarthria, altered level of consciousness, or other changes in sensory and motor function favor the presence of a central cause of vertigo. In order to establish the cause of vertigo, it is also useful to know the severity of vertigo over time; indeed in Ménière\'s disease, vertigo attacks initially increase in severity, whereas their severity decreases later on; in acute vestibular neuronitis, instead, initial symptoms typically are severe but decrease during the subsequent days.\[[@ref17][@ref31]\]

Physicians should also pay particular attention to physical findings of the neurologic, head and neck, and cardiovascular systems. Laboratory tests such as electrolytes, glucose, blood counts, and thyroid function tests allow identifying the etiology of vertigo in less than 1 percent of patients. These tests result are appropriate when patients with vertigo exhibit signs or symptoms that suggest the presence of other causes.\[[@ref31]\]

Finally, physicians should consider neuroimaging studies in patients with vertigo, which present neurologic signs and symptoms, progressive unilateral hearing loss, or risk factors for cerebrovascular disease. Magnetic resonance of the posterior fossa vasculature may be useful in diagnosing vascular causes of vertigo such as vertebrobasilar insufficiency, thrombosis of the labyrinthine artery, anterior or posterior inferior cerebellar artery insufficiency, and subclavian steal syndrome. Magnetic resonance can be used to exclude large bacterial infections, neoplasms, or developmental abnormalities, if other symptoms suggest one of these diagnoses. However, neuroimaging studies are not indicated in patients with BPPV and usually are not needed to diagnose acute vestibular neuronitis or Meniere\'s disease.\[[@ref17][@ref18][@ref24][@ref25][@ref26][@ref31]\]

The aim of this study was to analyze the data, received in our Regional Center of Documentation and Information on the Drug (Mater Domini Hospital, Catanzaro) in 2012, concerning the occurrence of vertigo and dizziness, as adverse effect of certain classes of drugs and report a brief review of the drugs that may induce such ADRs.

MATERIALS AND METHODS {#sec1-2}
=====================

We have analyzed 22 reports, received in our Regional Center of Documentation and Information on the Drug in 2012, concerning the occurrence of vertigo and dizziness, as ADRs of certain classes of drugs. The reporting cards of ADRs have been compiled by hospital doctors, specialists, general practitioners, and pharmacists who work in "Mater Domini" Hospital of Catanzaro (Calabria, Italy), in "Pugliese-Ciaccio" Hospital of Catanzaro (Calabria, Italy), in Hospital of Cosenza (Calabria, Italy), in Hospital of Reggio Calabria (Calabria, Italy), and in the LSC (Local Sanitation Company) of Catanzaro (Calabria, Italy), Crotone (Calabria, Italy), Vibo Valentia (Calabria, Italy), Reggio Calabria (Calabria, Italy), Paola (Calabria, Italy), Lamezia Terme (Calabria, Italy), Cosenza (Calabria, Italy), and Locri (Calabria, Italy).

RESULTS {#sec1-3}
=======

Analyzing the data concerning the reports of vertigo and dizziness as ADRs in 2012, it was found that, half of these reports comes from the use of anti-epileptic drugs such as lamotrigine,\[[@ref32]\] oxcarbazepine\[[@ref32]\] and carbamazepine\[[@ref32]\] (blockers of the voltage-gated sodium channels), lacosamide\[[@ref33]\] (drug that, *in vitro*, selectively enhances slow inactivation of voltage-gated sodium channels, resulting in stabilization of hyperexcitable neuronal membranes), and clonazepam\[[@ref34]\] (benzodiazepine with strong anticonvulsant properties) used in partial and generalized seizures, including tonic-clonic seizures, in focal seizures and mixed forms, alone or in combination with other drugs. Furthermore, from our analysis, it was found that drugs belonging to the class of antihypertensives may also cause vertigo or dizziness as adverse effect, more precisely the calcium antagonist amlodipine\[[@ref35]\] (a long-acting calcium channel blocker, belonging to the class of dihydropyridines), and the association between irbesartan\[[@ref36]\] (angiotensin-II receptor blockers or ARB) and hydrochlorothiazide\[[@ref37]\] (thiazide diuretic). Our results have also shown that anti-depressant drugs, such as mirtazapine\[[@ref38]\] (presynaptic α2-antagonist active at central level, which induces an increase in central noradrenergic and serotonergic neurotransmission and antagonist of H1-histaminergic receptors), paroxetine\[[@ref39]\] (potent and selective serotonin reuptake inhibitor), and sertraline\[[@ref39]\] (selective serotonin reuptake inhibitor) often are able to induce vertigo/dizziness accompanied by asthenia. Furthermore, from the analysis of our data, it was observed that antibiotics such as ciprofloxacin\[[@ref40]\] (a fluoroquinolone antibacterial agent) and the association between amoxicillin and clavulanic acid\[[@ref41]\] (β-lactam antibiotic) may induce adverse reactions characterized by dyspnea, nausea, and dizziness. Finally, after analyzing our data, it was noted that other drugs can possibly induce vertigo or dizziness, such as silodosin\[[@ref42]\] (drug useful in the treatment of the signs and symptoms of benign prostatic hyperplasia, highly selective for α1A-adrenoreceptors), pantoprazole\[[@ref43]\] (proton pump inhibitor), lornoxicam\[[@ref44]\] (non-steroidal anti-inflammatory drug, belonging to the class of oxicams, with analgesic properties), aripiprazole\[[@ref45]\] (effective antipsychotic in schizophrenia and in bipolar disorder type I), and atazanavir\[[@ref46]\] (azapeptide HIV-1 protease inhibitor).

A list of drugs that may cause, among the side-effects, vertigo or dizziness is reported in [Table 2](#T2){ref-type="table"}.

###### 

Classification of drugs that may cause vertigo or dizziness as an ADR
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DISCUSSION {#sec1-4}
==========

The list of drugs that may cause vertigo or dizziness is impressive. It includes anti-convulsants, anesthetics, anti-depressants, analgesics, anti-diabetics, contraceptives, anti-inflammatory drugs, cardiovascular drugs, sedatives, tranquillizers, cytotoxic agents, and anti-hypertensive agents.\[[@ref29][@ref30]\] The main purpose of this study was that to examine the data, received in our Regional Center of Documentation and Information on the Drug (Mater Domini Hospital, Catanzaro, Calabria, Italy) in 2012, related to the occurrence of vertigo and dizziness, as adverse effect of certain drugs.

From the assessment of the reporting cards, it was found that drugs with anti-convulsant properties, such as oxcarbazepine, carbamazepine, lamotrigine, lacosamide may cause vertigo or dizziness. As already reported, oxcarbazepine, useful in the symptomatic treatment of pain associated with neuropathies, is well tolerated with the most common adverse events consisting of vertigo, tremor, somnolence, hypotension, and nausea.\[[@ref47][@ref48]\] Most of the side-effects associated with carbamazepine therapy are mild, transient, and reversible with an adjustment in dosage or rate of dosage increase. In a study of the incidence of side-effects in 220 children below the age of 16 years who were receiving carbamazepine, drowsiness, loss of coordination, and vertigo were the most commonly observed side-effects.\[[@ref49]\] Under continuous, long-term use of valproate-lamotrigine, as found in a study, four patients presented heterogeneous disturbances, including vertigo.\[[@ref50]\] Lacosamide, efficacy for treatment of patients with partial seizures, is well tolerated, and the most common adverse events are unspecific central nervous system and gastrointestinal effects such as dizziness, vertigo, nausea, and headache.\[[@ref51][@ref52]\]

From our analysis, it was also possible to verify that vertigo or dizziness can also be caused by anti-hypertensive drugs, such as amlodipine and the irbesartan-hydrochlorothiazide association. In a previous study, it was found that the overall incidence of adverse reactions due to the use of the telmisartan-amlodipine combination in the treatment of hypertension was 7.69% with headache (1.92%) and vertigo (1.44%) as the commonest side-effects.\[[@ref53]\]

Furthermore, as found in reporting cards, among the side-effects of several anti-depressant (mirtazapine and SSRI) and antibiotics drugs (ciprofloxacin or amoxicillin-clavulanic acid association), even vertigo or dizziness were included. It is known that the abrupt discontinuation from the selective serotonin reuptake inhibitor (SSRI) category of anti-depressants commonly causes dizziness or vertigo.\[[@ref54]\] The efficacy and toxicity of ciprofloxacin, an orally administered fluoroquinolone, were evaluated in 24 infections in 23 patients with osteomyelitis caused by aerobic gram-negative bacilli. Eosinophilia, nausea, mild elevation in transaminase levels, pruritus, diarrhea, rash, and mild leucopenia were minimal side-effects in most patients, whereas vertigo and acute renal failure were severe reactions.\[[@ref55]\]

Finally, from our study, we found that drugs such as silodosin, pantoprazole, lornoxicam, aripiprazole, and atazanavir also induce adverse reactions characterized by vertigo or dizziness. Safety studies of silodosin, a new α1A-adrenoceptor selective antagonist, in healthy Chinese male subjects showed that mild adverse events, including dizziness, postural hypotension, and headache, were observed.\[[@ref56]\] Pantoprazole (40 mg once daily) appears to be well tolerated during short term oral administration, with diarrhea (1.5%), headache (1.3%), dizziness (0.7%), pruritus (0.5%), and skin rash (0.4%) representing the most frequent adverse events.\[[@ref57]\] Acute aripiprazole poisonings most commonly result in vertigo or dizziness, sedation, sinus tachycardia, nausea / vomiting, or dystonic reactions.\[[@ref58]\]

Pharmacovigilance is the science, which allows physicians to have sufficient information related to drugs also increasing knowledge about drug safety. It is based on the spontaneous reporting of events that are supposed to be adverse effects of drugs.\[[@ref59][@ref60]\] According to the World Health Organization (WHO), an adverse drug reaction is "*a response to a drug that is noxious and unintended and occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for modification of physiological function*."\[[@ref61]\] Pharmacovigilance through, for example, spontaneous ADR reporting or large-scale databases, is used to generate hypotheses and signals about potential hazards of marketed drugs that require further investigation. Spontaneous reporting of suspected ADRs is particularly useful in identifying rare or delayed reactions; as such a system enables medicines to be monitored throughout their lifetime.\[[@ref60]\]

In our study, the analysis of the spontaneous reports of vertigo or dizziness as side-effect of certain drugs, received at our Pharmacovigilance Center, located in Mater Domini Hospital (Catanzaro, Calabria, Italy) has been a precious instrument that has allowed to increase the knowledge concerning the safety and toxicity profile of these drugs; however, for some of them, their ability to induce vertigo or dizziness was already reported in literature. The fact that this group of ADRs only represents 5% of all reported in 2012 and that instead such ADRs are so common for several drug groups might indicate that they are under-reported. This is probably linked to the already known appearance of vertigo/dizziness for several drugs and that in most cases it is no serious or might disappear during treatment. Nevertheless, all ADRs represent a reduction in quality of life and more specifically, vertigo and dizziness might represent an indirect cause of serious adverse events due to falls and subsequent fractures or traumas.

In conclusion, all ADRs should not be under-estimated; safety improvement and patients' quality of life remain one of the major objectives during pharmacological treatment.
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